Seven cases of successfully treated Candida albicans cerebrospinal fluid shunt infections are reported. Treatment consisted of shunt removal and intravenous Amphoteracin B in all cases and intraventricular Amphoteracin B in 4 cases. Serious underlying medical illness, recent antibiotic therapy, indwelling intravascular and/or Foley catheters, coincident candidiasis and low birth weight prematurity are major risk factors for candida shunt infection. Candida shunt infection appears to occur by either contamination at the time of shunt placement or by hematogenous dissemination.
|Original language||English (US)|
|Number of pages||6|
|State||Published - Dec 1 1989|
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Clinical Neurology